Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (319)
ARTG (296)
Prescription medicine registration (28)
Designation or determination (2)
Prescription medicine evaluation (2)

Date

2026 (39)
2025 (30)
2024 (51)
2023 (161)
2022 (30)
2021 (55)
2020 (48)
2019 (26)
2018 (53)
2017 (35)
2016 (77)
2015 (2)
2014 (2)
2013 (9)
2012 (10)
2011 (2)
2010 (10)
2008 (2)
2002 (2)
2001 (3)

Search

Sponsor content

647 result(s) found, displaying 411 to 420

TADALAFIL-RZ tadalafil 2.5 mg film-coated tablet bottle (285594)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-RZ tadalafil 2.5 mg film-coated tablet bottle.
TADALAFIL-DRLA tadalafil 2.5 mg film-coated tablet bottle (285611)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-DRLA tadalafil 2.5 mg film-coated tablet bottle.
TADALAFIL-DRLA tadalafil 20 mg film-coated tablet bottle (285596)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-DRLA tadalafil 20 mg film-coated tablet bottle.
TADALAFIL-RZ tadalafil 5 mg film-coated tablet bottle (285602)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-RZ tadalafil 5 mg film-coated tablet bottle.
VALSARTAN-DRLA valsartan 40mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
VALSARTAN-DRLA valsartan 80mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
VALSARTAN-DRLA valsartan 160mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
VALSARTAN-DRLA valsartan 320mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
DR REDDY'S IRBESARTAN irbesartan 75 mg film coated tablet bottle Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
DR REDDY'S IRBESARTAN irbesartan 300 mg film coated tablet bottle Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd

Pages

First page
Previous page
…
Page 38
Page 39
Page 40
Page 41
Current page 42
Page 43
Page 44
Page 45
Page 46
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.